Skip to main content

Peer Review reports

From: The efficacy of gabapentin for the treatment of refractory cough associated with interstitial lung disease: study protocol for a randomized, double-blind and placebo-controlled clinical trial

Original Submission
31 Aug 2021 Submitted Original manuscript
10 Nov 2021 Reviewed Reviewer Report - Muslim Syed
10 Jan 2022 Reviewed Reviewer Report - Fernando Zanela da Silva Arêas
24 Jan 2022 Author responded Author comments - Ronglin Gao
Resubmission - Version 2
24 Jan 2022 Submitted Manuscript version 2
27 Jan 2022 Editorially accepted
21 Feb 2022 Article published 10.1186/s13063-022-06059-5

You can find further information about peer review here.

Back to article page